about
Nanoplatforms for constructing new approaches to cancer treatment, imaging, and drug delivery: what should be the policy?siRNA Versus miRNA as Therapeutics for Gene SilencingDendrimers in drug delivery and targeting: Drug-dendrimer interactions and toxicity issuesMicelle-like nanoparticles as carriers for DNA and siRNAMitigating the looming vaccine crisis: production and delivery of plasmid-based vaccinesNanoinformatics: a new area of research in nanomedicineRecent progress in the construction of cavity-cored supramolecular metallodendrimers via coordination-driven self-assembly.Janus-type dendrimer-like poly(ethylene oxide)sAcetylation of PAMAM dendrimers for cellular delivery of siRNA.Antibacterial activity and cytotoxicity of PEGylated poly(amidoamine) dendrimers.Synthesis and characterization of photocurable polyamidoamine dendrimer hydrogels as a versatile platform for tissue engineering and drug deliveryFunctional delivery of siRNA in mice using dendriworms.Microscopic basis for the mesoscopic extensibility of dendrimer-compacted DNA.Gold nanoparticles for nucleic acid delivery.Systemic antiangiogenic activity of cationic poly-L-lysine dendrimer delays tumor growth.Peptide and glycopeptide dendrimers and analogous dendrimeric structures and their biomedical applications.Synthesis and inhibition study on tripeptide inhibitor modified poly(L-lysine) dendrimers.Dendrimers: synthesis, applications, and properties.Current status of non-viral gene therapy for CNS disorders.Physicochemical and biological properties of self-assembled antisense/poly(amidoamine) dendrimer nanoparticles: the effect of dendrimer generation and charge ratioStructure-skin permeability relationship of dendrimers.Labile catalytic packaging of DNA/siRNA: control of gold nanoparticles "out" of DNA/siRNA complexesLipid and polymeric carrier-mediated nucleic acid delivery.Surface conjugation of triphenylphosphonium to target poly(amidoamine) dendrimers to mitochondria.The potential of nanomedicine therapies to treat neovascular disease in the retina.Exploring the efficiency of gallic acid-based dendrimers and their block copolymers with PEG as gene carriers.Optimizing nanomedicine pharmacokinetics using physiologically based pharmacokinetics modelling.Biomaterial constructs for delivery of multiple therapeutic genes: a spatiotemporal evaluation of efficacy using molecular beacons.Lipid-mediated DNA and siRNA Transfection Efficiency Depends on Peptide HeadgroupPreparation of a Nanoscaled Poly(vinyl alcohol)/Hydroxyapatite/DNA Complex Using High Hydrostatic Pressure Technology for In Vitro and In Vivo Gene Delivery.DNA compaction induced by a cationic polymer or surfactant impact gene expression and DNA degradationConjugation of poly(amidoamine) dendrimers with various acrylates for improved delivery of plasmid encoding interleukin-12 gene.Topical gene silencing by iontophoretic delivery of an antisense oligonucleotide-dendrimer nanocomplex: the proof of concept in a skin cancer mouse model.Identification of possible cytotoxicity mechanism of polyethylenimine by proteomics analysis.Magnetic resonance-guided regional gene delivery strategy using a tumor stroma-permeable nanocarrier for pancreatic cancerTumor regression following intravenous administration of lactoferrin- and lactoferricin-bearing dendriplexes.Dynamic PolyConjugates for targeted in vivo delivery of siRNA to hepatocytes.Particle-based technologies for osteoarthritis detection and therapy.Targeted Gene Delivery to MCF-7 Cells Using Peptide-Conjugated PolyethylenimineCatalytic self-assembly of a DNA dendritic complex for efficient gene silencing.
P2860
Q24599399-7753D8A8-07D4-4907-BB61-0B0FA8987A6EQ26786876-6D2A565C-B456-4E18-8F24-C7E6E4EC82C7Q26825175-36F25FE1-9A45-4EDC-956D-86549C2CEAF8Q27001558-1350DC06-8218-4BB0-84DD-84E166F3D76EQ28294355-F189DC2A-DCEB-48A8-82FB-AD05D74391C2Q28387114-6D916A93-3EDB-44CA-925B-BA5A8B9A5AB0Q30689640-8D175482-8E3D-410E-B29D-F053C573DCE2Q33357782-D20B468A-1FB3-444D-BCC9-0BC0FC747200Q33434160-D0F7DD5B-FB07-4CE3-8472-3FA310ABCC63Q33503674-B267ACBF-E453-47E7-BC7D-5EF3EE3C8864Q33527081-6E0ECA9D-0C58-4F32-8B2B-9A7EF39CAD72Q33686651-C5B4D035-5E48-4D96-B6D1-ADC97C59987CQ33696080-B2158DC5-74F2-4488-99CF-ED6B4BBA3BD6Q33724219-C3D1660D-D9DF-4089-99E6-450A3BCA7D92Q33732629-1B35F536-3B40-4508-91CA-F4D798B21290Q33740696-73B428F1-A53E-4D5F-938D-379AEBE0CA3CQ33760205-F30FBF35-2F6B-46C4-8EEE-16AEE498C9AAQ33820501-B4443C0A-7FA8-4BB2-A5A4-DEE15F717081Q33824159-DB7291A8-3FCC-4A81-8BAC-6D79764AC27EQ33874029-74F96D5E-EFE4-40DA-97C9-E102A98D14E9Q33919858-8617BA67-9093-406C-8A71-96617DE7B968Q34058107-F821ACDA-1AE0-440A-AF65-4B43B97D20D1Q34155795-9819C7F2-254B-430D-8267-608343AF4B6CQ34217027-2EA55C1E-A13F-4294-BEEA-2A748B7C2678Q34220590-C18A1E04-FC5A-4847-99ED-64EA9066CEA0Q34343876-4242AE5A-D2EE-4134-B5ED-480C723C57E5Q34571360-FB625912-1117-4E49-90CE-A4B1E7BEBCA2Q34766733-792B43A3-F93C-4655-9996-D7B9C649B788Q35082289-4D3B79AE-EFB3-458F-AFCD-4F597A0E4BB3Q35101140-E4D77E57-7DEC-4CC1-B626-5E6AB7D035FEQ35132218-9D075FFB-F537-428B-B026-D86EC47FEE11Q35247054-D69AB942-7448-4939-B45C-9FA440D838D7Q35462632-5E0D23A3-F62F-4A01-A2A9-9DDE027D7132Q35680941-A62B4DA5-7403-4B7C-99E8-6FF6EA70144FQ35867668-0DF64BA3-35B5-447F-9EF6-88AF486CB6C3Q35871833-8D2E1782-6BC6-4954-A08D-9ADB0E18BABFQ35928850-904EE573-3E2B-4B2A-B196-2C21E53753AAQ36303687-E97ED587-81CB-430D-9DF9-7A0537E28072Q36360538-41F7B70A-870A-412B-8697-C65D7E44C099Q36463847-6750A7BD-C8FE-4E10-95C2-58FEC58546F8
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
2005年學術文章
@zh
2005年學術文章
@zh-hant
name
Dendrimers in gene delivery.
@ast
Dendrimers in gene delivery.
@en
type
label
Dendrimers in gene delivery.
@ast
Dendrimers in gene delivery.
@en
prefLabel
Dendrimers in gene delivery.
@ast
Dendrimers in gene delivery.
@en
P50
P1476
Dendrimers in gene delivery.
@en
P304
P356
10.1016/J.ADDR.2005.09.017
P407
P577
2005-11-28T00:00:00Z